 |
|
Psychosocial Aspects of HIV Treatment—Reply
|
|
| Since this article does not have an abstract, we have provided the first 107 words of the full text and any section headings. |
|
|
|
In Reply: We thank Dr Brousseau for highlighting the importance of mental health issues in the management of persons with HIV infection. In the context of antiretroviral therapy, our mention of comorbid conditions, patient readiness, and the importance of regimen adherence were all meant to subsume the myriad psychosocial challenges that patients face. We agree that consideration of these issues is crucial to successful antiretroviral therapy and appreciate the clarification.
Financial Disclosures: Dr Hammer reported having received grants and research support from Merck, having served as a scientific advisor to Boehringer-Ingelheim, Progenics, Pfizer, and Tibotec-Virco, and serving on a data and safety monitoring board for Bristol-Myers Squibb.
Scott M. Hammer, MD
smh48@columbia.edu
Columbia University College of Physicians & Surgeons
New York, NY
for the International AIDS Society-USA Antiretroviral Therapy Panel
Letters Section Editor: Robert M. Golub, MD, Senior Editor.
JAMA. 2007;297:158.
RELATED LETTER
Psychosocial Aspects of HIV Treatment
Kristin Brousseau
JAMA. 2007;297(2):157-158.
EXTRACT
| FULL TEXT
RELATED ARTICLE
Treatment for Adult HIV Infection: 2006 Recommendations of the International AIDS Society–USA Panel
Scott M. Hammer, Michael S. Saag, Mauro Schechter, Julio S. G. Montaner, Robert T. Schooley, Donna M. Jacobsen, Melanie A. Thompson, Charles C. J. Carpenter, Margaret A. Fischl, Brian G. Gazzard, Jose M. Gatell, Martin S. Hirsch, David A. Katzenstein, Douglas D. Richman, Stefano Vella, Patrick G. Yeni, and Paul A. Volberding
JAMA. 2006;296(7):827-843.
ABSTRACT
| FULL TEXT
|
